LENZ Therapeutics (LENZ) Insider Trading & Ownership $29.96 +0.19 (+0.64%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$30.10 +0.14 (+0.47%) As of 08/1/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LENZ Therapeutics (NASDAQ:LENZ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.90%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$15.50MNumber OfInsiders Selling(Last 3 Years)0 Get LENZ Insider Trade Alerts Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LENZ Insider Buying and Selling by Quarter LENZ Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/13/2024James W MccollumDirectorBuy31,332$15.99$500,998.68 3/21/2024Ra Capital Management, L.P.DirectorBuy998,009$15.03$15,000,075.27 (Data available from 1/1/2013 forward) LENZ Insider Trading Activity - Frequently Asked Questions Who is on LENZ Therapeutics' Insider Roster? The list of insiders at LENZ Therapeutics includes James W Mccollum, and Ra Capital Management, L.P.. Learn more on insiders at LENZ. What percentage of LENZ Therapeutics stock is owned by insiders? 6.90% of LENZ Therapeutics stock is owned by insiders. Learn more on LENZ's insider holdings. Which LENZ Therapeutics insiders have been buying company stock? The following insiders have purchased LENZ shares in the last 24 months: James W Mccollum ($500,998.68), and Ra Capital Management, L.P. ($15,000,075.27). How much insider buying is happening at LENZ Therapeutics? Insiders have purchased a total of 1,029,341 LENZ shares in the last 24 months for a total of $15,501,073.95 bought. LENZ Therapeutics Key ExecutivesMr. Evert B. Schimmelpennink (Age 52)President, CEO, Secretary & Director Compensation: $886.54kMr. Shawn Olsson (Age 41)Chief Commercial Officer Compensation: $532.13kMr. Marc G. Odrich M.D. (Age 65)Chief Medical Officer Compensation: $576.95kMr. James W. McCollum (Age 69)Co-Founder & Director Mr. Gerald HornSenior Scientific Advisor & FounderMr. Daniel R. Chevallard CPA (Age 44)Chief Financial Officer Mr. Domenick PorfidiaVice President of SalesMr. David MurphySenior Director of Marketing & Alliance DevelopmentMr. Marvin J. Garrett (Age 73)Senior Vice President of Regulatory & Quality More Insider Trading Tools from MarketBeat Related Companies PTCT Insider Trading SWTX Insider Trading MLTX Insider Trading PTGX Insider Trading KYMR Insider Trading CRNX Insider Trading IMVT Insider Trading OGN Insider Trading NAMS Insider Trading RXRX Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:LENZ) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENZ Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
